- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04172415
Current Procedural Sedation Practices in a Canadian Community Emergency Department
Current Procedural Sedation Practices for Adults and Children in a Canadian Community Emergency Department
Study Overview
Detailed Description
Procedural sedation is a common practice in the Emergency Department setting. The purpose of procedural sedation is to provide adequate pain relief to patients undergoing an emergent procedure. As a result, the time to the patient's symptom relief, the degree of side effects and the duration of action of the medication are all critical to selecting an appropriate sedative and/or analgesic.
The community hospital setting may present unique challenges to successfully administering procedural sedation techniques. Funding and resource allocation can limit patient access to timely sedation/analgesia. This can be compounded by prolonged stays in the Emergency Department for recovery and/or complications.
The current recommendations for 'Procedural Sedation and Analgesia in the Emergency Department' outlines recommended medications and policies for adults and children undergoing procedural sedation1,2. While a number of cohort and retrospective analyses have been done in a variety of research settings, the role for oral or intranasal anesthesia has not been adequately explored in ED settings. The initial phase of this research proposal will identify current local practices through chart review analysis collected over the last year. Subsequent research questions might include a comparative analysis of the current procedural sedation techniques compared to medications administered orally or by inhalation. This may have considerable future benefit to patient satisfaction and clinical outcomes, as well as resource and operational outcomes in the Emergency Department.
Hypothesis
To identify interventions requiring procedural sedation and the medication commonly used in a Canadian community emergency department (ED). Using standardized medical record review methods, primary clinical patient indicators, safety outcomes and secondary ED operational outcomes will be reviewed.3
Study Design
This retrospective chart review will be obtained from data of patients who have registered in the Welland County General Hospital (WHS) from the dates of January 2017 -December 2018. This timeframe should capture a sample size of ~300 patients.
Patients will be included in our study if they have received conscious sedation for a diagnostic or therapeutic procedure in the emergency department. They will be identified through review of billing records for anesthesia codes. Medical records, specifically physician procedural sedation records and nursing documentation, will be our main resources for data extraction. The investigators will describe and quantify the procedures requiring conscious sedation and identify the medication (and route) used, using a standardized data abstraction tool to be created from international ED PSA guidelines.1,2 Primary outcome measures will include ED PSA indications, pre-procedural assessments (medical comorbidities, difficult airway predictors, other safety factors), medications used, sedation failures/use of rescue medications, procedural successes or failures, post-PSA assessments, PSA recovery and patient disposition. Further stratification by age and other demographic features will help us better understand trends between the adult and pediatric population.
Patients requiring anaesthesia for the purpose of intubation and ventilator support will be excluded from this study.
Our secondary outcomes involve resource utilization and complications. Duration of procedure and time to discharge will be measured. Data on adverse outcomes and unplanned admission rates will also be collected. Adverse outcomes of interest will be vomiting, medication for blood pressure support, dysrhythmias, unanticipated intubation, laryngospasm, pulse oximetry less than 90%, apnea requiring bag-valve-mask ventilation and death.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Ontario
-
St Catharines, Ontario, Canada, L2S 0A9
- Niagara Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients who have registered in the Welland County General Hospital Emergency Department (WHS) from the dates of January 2017-December 2018.
- Patients who require procedural sedation in the Emergency Department
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Retrospective cohort
Patients that received procedural sedation in a community Emergency Department.
|
Chart Review
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedural Sedation
Time Frame: 2 years
|
Total number of patients requiring conscious sedation
|
2 years
|
|
Medication Use
Time Frame: 2 years
|
The number and type of medications used during procedure
|
2 years
|
|
Pre Procedural Assessment Findings
Time Frame: 2 years
|
ASA score, 3-3-2 Abnormality, Pre-procedure Fast, Mallampatie Class, Neck Obesity, Facial Hair
|
2 years
|
|
Sedation Failures and Use of Rescue Medications
Time Frame: 2 years
|
Number of occurrences where sedation is inadequate for treatment and number/type of rescue medication used to achieve adequate sedation
|
2 years
|
|
Time of Discharge
Time Frame: 2 years
|
Time of patient discharge or transfer from Emergency Department
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Length of time spent in Emergency Department
Time Frame: 2 years
|
2 years
|
|
Duration of Procedure and Time to discharge
Time Frame: 2 years
|
2 years
|
|
Number of Adverse Outcomes
Time Frame: 2 years
|
2 years
|
|
Rate of Hospital Admission
Time Frame: 2 years
|
2 years
|
|
Time from Triage to initiation of procedural sedation
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7148-C
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Conscious Sedation
-
Fatih Sultan Mehmet Training and Research HospitalCompletedProcedural Sedation | Conscious SedationTurkey (Türkiye)
-
Menoufia UniversityCompleted
-
Ethicon Endo-SurgeryTerminated
-
Orion Corporation, Orion PharmaTerminated
-
University Hospital Inselspital, BerneGE HealthcareCompletedCritical Care | Conscious Sedation | Deep SedationSwitzerland
-
Indiana UniversityCompletedConscious SedationUnited States
-
Hadassah Medical OrganizationCompleted
-
University Medical Centre LjubljanaUnknown
-
Hospira, now a wholly owned subsidiary of PfizerMaruishi PharmaceuticalCompleted
-
University Hospital, Basel, SwitzerlandCompletedConscious SedationSwitzerland
Clinical Trials on Retrospective cohort
-
Seoul National University HospitalRecruiting
-
Virginia Commonwealth UniversityThermo Fisher Scientific, IncRecruitingKidney Transplant RejectionUnited States
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCompletedNecrotizing EnterocolitisChina
-
Guangzhou Women and Children's Medical CenterCompletedNecrotizing EnterocolitisChina
-
Azienda Ospedaliera Specializzata in Gastroenterologia...CompletedDiabetes Mellitus, Type 2Italy
-
Clinical Research Centre, MalaysiaHospital Queen Elizabeth, MalaysiaTerminatedCovid19 | Critically IllMalaysia
-
Istituto Romagnolo per lo Studio dei Tumori Dino...RecruitingDiffuse Large B Cell LymphomaItaly
-
The First Hospital of Jilin UniversityCompleted
-
Institut BergoniéBayerCompletedMetastatic Solid TumorsFrance
-
Erol Olcok Corum Training and Research HospitalCompleted